JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Miscellaneous | 24.97% |
| 3 | Financials | 9.75% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Healthcare | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3451
Qfin Holdings
QFIN
$785M
| $3.8M | ﹤0.01% |
197,033
-307,932
| -61% | -$6.92M |
2021 Q2
18 quarters
|
|
|
BRSL
3452
Brightstar Lottery PLC
BRSL
$1.8B
| $3.79M | ﹤0.01% |
244,866
-560,776
| -70% | -$9.14M |
2013 Q2
50 quarters
|
|
3453
Adtran
ADTN
$574M
| $3.78M | ﹤0.01% |
435,184
-378,179
| -46% | -$3.28M |
2015 Q3
41 quarters
|
|
3454
iShares Core 5-10 Year USD Bond ETF
IMTB
$264M
| $3.78M | ﹤0.01% |
85,515
+12,003
| +16% | +$531K |
2021 Q3
17 quarters
|
|
3455
Takeda Pharmaceutical
TAK
$57.1B
| $3.78M | ﹤0.01% |
242,179
-5,350
| -2% | -$76.5K |
2018 Q4
28 quarters
|
|
|
BTC
3456
Grayscale Bitcoin Mini Trust ETF
BTC
$4.46B
| $3.77M | ﹤0.01% |
97,380
+18,799
| +24% | +$833K |
2024 Q3
5 quarters
|
|
3457
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.25B
| $3.77M | ﹤0.01% |
17,091
-124
| -0.7% | -$26.9K |
2025 Q2
2 quarters
|
|
3458
SI-BONE Inc
SIBN
$810M
| $3.77M | ﹤0.01% |
191,105
+5,486
| +3% | +$95.3K |
2018 Q4
28 quarters
|
|
|
AIV
3459
Aimco
AIV
$280M
| $3.76M | ﹤0.01% |
633,398
-33,256
| -5% | -$199K |
2013 Q2
50 quarters
|
|
3460
White Mountains Insurance
WTM
$4.82B
| $3.75M | ﹤0.01% |
1,806
-2,516
| -58% | -$4.92M |
2017 Q4
32 quarters
|
|
3461
CALL
US Bancorp Series B Preferred Stock
USB.PRH
$733M
| $3.74M | ﹤0.01% |
70,000
-121,500
| -63% | -$2.27M |
2024 Q3
5 quarters
|
|
|
CNL
3462
Collective Mining Ltd
CNL
$1.12B
| $3.73M | ﹤0.01% |
255,644
-14,370
| -5% | -$175K |
2024 Q3
5 quarters
|
|
3463
Lionsgate Studios
LION
$3.32B
| $3.71M | ﹤0.01% |
406,709
+65,109
| +19% | +$463K |
2024 Q4
4 quarters
|
|
3464
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.15B
| $3.71M | ﹤0.01% |
126,390
+34,406
| +37% | +$1.02M |
2023 Q3
9 quarters
|
|
3465
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.34B
| $3.71M | ﹤0.01% |
75,326
+8,890
| +13% | +$441K |
2022 Q1
15 quarters
|
|
3466
Zevra Therapeutics
ZVRA
$593M
| $3.69M | ﹤0.01% |
412,261
-26,723
| -6% | -$253K |
2021 Q2
18 quarters
|
|
3467
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$10.9B
| $3.69M | ﹤0.01% |
109,240
-683,154
| -86% | -$23.1M |
2015 Q4
40 quarters
|
|
3468
Sweetgreen
SG
$1.08B
| $3.68M | ﹤0.01% |
544,959
+329,362
| +153% | +$2.26M |
2021 Q4
16 quarters
|
|
3469
CALL
Abeona Therapeutics
ABEO
$288M
| $3.68M | ﹤0.01% |
+699,000
| New | +$3.52M |
2025 Q4
0 quarters
|
|
3470
Oppenheimer Holdings
OPY
$1.29B
| $3.67M | ﹤0.01% |
50,800
-18,638
| -27% | -$1.3M |
2013 Q2
50 quarters
|
|
3471
CALL
iShares Gold Trust
IAU
$61.5B
| $3.65M | ﹤0.01% |
+45,000
| New | +$3.52M |
2025 Q4
0 quarters
|
|
3472
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.3B
| $3.65M | ﹤0.01% |
37,319
+2,135
| +6% | +$210K |
2020 Q3
21 quarters
|
|
|
FPI
3473
Farmland Partners
FPI
$490M
| $3.64M | ﹤0.01% |
375,609
-133,785
| -26% | -$1.34M |
2016 Q1
39 quarters
|
|
3474
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
$9.71B
| $3.64M | ﹤0.01% |
109,962
+10,469
| +11% | +$342K |
2022 Q4
12 quarters
|
|
3475
Cogent Communications
CCOI
$433M
| $3.64M | ﹤0.01% |
168,603
-371,167
| -69% | -$11M |
2015 Q1
43 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $106B in Q4 2025, closing 563 positions and reducing 3,329 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.